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Abstract  
Macrophages are present in large numbers in every tissue in the body where they play critical roles in 
development and homeostasis. They exhibit remarkable phenotypic and functional diversity, 
underpinning their adaptation to specialized roles in each tissue niche. CSF1, signaling through the 
CSF1 Receptor (CSF1R), which is restricted to monocyte-macrophage lineage cells in adults, is a critical 
growth factor controlling macrophage proliferation, differentiation and many aspects of mature 
macrophage function. We have generated a macrophage reporter rat, utilizing a construct containing 
elements of the mouse Csf1r promoter and the highly conserved Fms intronic regulatory element 
(FIRE) to drive mApple fluorescent protein expression. Csf1r-mApple was robustly expressed in 
monocyte-macrophage lineage cells in rat bone marrow, peripheral blood and tissues, with 
detectable expression in granulocytes and B cells and no evidence of expression in hematopoietic 
precursors or non-hematopoietic cells. Here, we use the Csf1r-mApple transgene to highlight and 
dissect the abundance and heterogeneity of rat tissue macrophage populations, and to demonstrate 
parallel increases in blood monocytes and multiple tissue macrophage populations, including bone 
marrow, liver, spleen and lung, in response to CSF1 treatment in vivo. The Csf1r-mApple rat is a novel 
tool enabling analysis of rat macrophages in situ by direct imaging and providing an additional 
phenotypic marker to facilitate exploration of rat tissue macrophage phenotypic and functional 
heterogeneity. 
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Introduction 
 
The laboratory rat has been studied extensively in models of cardiovascular, neurological, cancer, diabetes, 
respiratory and inflammatory diseases.[1, 2] Many of these diseases involve cells of the mononuclear 
phagocyte system (MPS, monocytes, tissue macrophages) in different states of activation as effectors and 
are associated with differential genetic susceptibility amongst rat strains (e.g.[3]). Macrophages are a 
prominent cell population in all major organs and adapt in each site to perform specific functions. In mice, 
resident tissue macrophages adopt unique transcriptional profiles to perform organ-specific functions in 
development and homeostasis.[4-7] There are few similar studies in the rat, in part because of the lack of 
macrophage markers to enable isolation and characterization of tissue macrophages or their localization in 
situ. However, transcriptomic analysis of the brain and spleen of Csf1r deficient rats[8] and of the liver of 
CSF1-treated rats[9] indicated that the macrophage populations of those organs (microglia in brain, marginal 
zone and red pulp in spleen and Kupffer cells in liver) share many tissue-specific adaptations with mouse.  
 
Analysis of monocyte-macrophage ontogeny, location and function in mice has been driven by the 
widespread availability of monoclonal antibodies against numerous cell surface proteins, fluorescent 
reporter transgenes, and conditional and constitutive mutations in the germ line. Amongst many other 
applications, these tools have enabled the dissection of the differentiation of subsets of peripheral blood 
monocytes in the mouse. Mammalian peripheral blood monocytes can be separated into subpopulations 
based upon surface markers; LY6C in mouse and CD14/CD16 in humans (Reviewed in [10]). The 
subpopulations are also distinguished by their expression of chemokine receptors CCR2 and CX3CR1 in 
humans, mice and rats.[11] Previous studies of rat monocyte heterogeneity have relied on differential 
expression of the E-selectin ligand sialophorin (CD43) and an undefined marker, HIS48, that is shared with 
granulocytes (expression is somewhat analogous to LY6C in mouse).[12, 13] CD43, which is highly expressed 
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on the non-classical monocyte population in rats,[11] is also highly expressed on LY6Clo and CD16hi non-
classical monocytes in mice[14, 15] and humans,[16] respectively. CD43 (SPN) mRNA is strongly up-regulated 
in CD16hi human monocytes relative to CD14hi classical monocytes. Most studies indicate that these 
populations are a developmental series, with the LY6Chi (mouse) or CD14hi (human) classical monocytes being 
short-lived immature precursors which may either leave the circulation or differentiate to long-lived 
progeny.[10, 17]  
 
The available macrophage markers for the rat are limited. There are, for example, no antibodies against rat 
CD115 (CSF1R), CD64, MERTK, TIMD4 or F4/80 (ADGRE1); each used widely to define subsets of resident 
tissue macrophages in the mouse. The mRNAs encoding these markers are highly-expressed by rat 
macrophages[3, 8, 9]. The most widely-used rat macrophage markers in tissues are still CD68 (ED1), CD163 
(ED2) and CD169 (ED3).[18] Recently antibodies were generated against rat macrophage C type lectins, 
MCL1 (CLEC4D) and MINCLE (CLEC4E),[19, 20] but these have not been widely utilized.  
 
The proliferation, differentiation and survival of cells of the MPS are controlled by signals from the 
macrophage colony-stimulating factor receptor (CSF1R), elicited by binding of its two ligands, CSF1 and 
IL34[21, 22]. Treatment of mice[23] or pigs[24] with a long-acting form of CSF1, CSF1-Fc, produced an 
expansion of blood monocyte and tissue macrophage populations. Conversely, a natural mutation of the Csf1 
gene (Csf1tl/tl)[25] or targeted mutagenesis of the Csf1r[8] gene in rats, as in mice[26], is associated with 
substantial loss of blood monocytes and most tissue macrophage populations. However, the pleiotropic 
consequences of that loss differ between the rodent species.[8] Whereas Csf1r mutation in mice is lethal 
prior to weaning on most genetic backgrounds,[27] Csf1r mutant rats are viable as adults.[8] 
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The regulatory elements of the mouse Csf1r locus, including a highly-conserved enhancer (the Fms intronic 
regulatory element (FIRE)) in the first intron, have been used in transgenic mice to drive fluorescent reporter 
gene expression[28, 29] and cre-recombinase for conditional mutagenesis and lineage tracing[30]. Csf1r 
reporter transgene expression appeared copy-number and position independent and was highly 
reproducible in multiple independent mouse founders. The Csf1r conserved elements also directed 
monocyte-macrophage reporter gene expression in transgenic chickens[31] and sheep[32]. In mice, 
granulocytes express Csf1r mRNA, but do not express Csf1r protein[28, 33]. Accordingly, both Csf1r-EGFP 
and Csf1r-mApple transgenes are expressed in mouse granulocytes, albeit at lower levels than in monocytes. 
The CSF1R-EGFP and Csf1r-mApple transgenes are also expressed at low levels in murine B cells, which, like 
macrophages, express the key transcription factor PU.1. The Csf1r locus is epigenetically-silenced during B 
lymphocyte differentiation[34]; presumably this regulation does not operate fully in a multicopy transgene. 
 
A major advantage of the rat as an experimental model is its much greater size, which permits isolation of 
large numbers of cells from major organs, experimental surgery including transplantation and dissection of 
structures such as lymphatics, lymph nodes and peripheral nerves[1]. By contrast to the extensive use of 
transgenic reporters in mice, there have been few reported in rats, mostly in the context of the neuronal[35-
38] and vascular/lymphatic[39, 40] systems. The recent generation of a cre-dependent reporter gene into 
the rat Rosa26 locus[41] promises rapid advances in applications of lineage tracing in rats, and more broadly 
the generation of defined mutations in the rat genome using CRISPR-Cas9.  
 
To enable greater utility of the rat as an experimental model for the study of CSF1 biology and tissue 
monocyte and macrophage populations in rats, including live imaging applications, we generated a Csf1r 
reporter transgene in this species. For this purpose, we chose mApple as a reporter, which was used 
previously to generate Csf1r reporter transgenic mice[28] and chick[31]. mApple has the advantage of 
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resistance to photobleaching[42] and there is relatively little background autofluorescence in this channel. 
Here we characterize the expression of the Csf1r-mApple reporter transgene in adult rats and utilize the 
reporter to demonstrate the impact of CSF1-Fc treatment on diverse tissue macrophage populations. 
 
Materials and Methods 
Generation of transgenic rats and animal maintenance. 
Csf1r-mApple transgenic fluorescent reporter rats were generated by pronuclear injection of a Csf1r-
mApple construct[28] into outbred Sprague-Dawley (SD) embryos under contract with Cyagen 
Biosciences (Santa Clara, USA). Wild type SD rats were obtained from the Animal Resource Center, 
Australia. Genotyping was performed by PCR analysis of genomic DNA isolated from ear notches using 
primers that amplify a 507 bp product within the Csf1r-mApple cassette (Forward: 
CCTACATGTGTGGCTAAGGA, Reverse: CTTGAAGTAGTCGGGGATGT).  Rats were bred and maintained 
in specific pathogen free facilities at the University of Queensland in accordance with the guidelines 
of The University of Queensland Animal Ethics Unit, under approved protocols. Csf1r-mApple+ 
founders were initially mated with wild type SD rats from a separate colony (ARC, Perth, Australia) 
and then with wild type littermates to avoid mating to homozygosity. Litter sizes averaged 15-17, and 
there was no evidence of a detrimental impact of the transgene knock-in in juvenile or adult rats.   
 
CSF1-Fc treatment 
Male (11 weeks old) and female (8 weeks old) rats were randomized into control and treatment 
cohorts and injected with saline or CSF1-Fc [23] (1 mg/kg) daily for 4 days in the loose skin over the 
flank. Animals were euthanized by CO2 inhalation and tissues were harvested on day 5. 
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Tissue collection for imaging and disaggregation for flow cytometry analysis 
Peripheral blood (100 ul) was routinely collected into EDTA tubes by cardiac puncture following 
euthanasia. Blood was subjected to hematology analysis (Mindray BC-5000) followed by red blood cell 
lysis for 2 minutes in ACK lysis buffer (150 mM NH4Cl, 10 mM KHCO3, 0.1 mM EDTA, pH 7.4) and 
resuspended in flow cytometry (FC) buffer (PBS/2 % FBS) for staining. In experiments designed to 
maximize recovery of the marginal pool of monocytes, rats were perfused through the left ventricle 
with 500 ml of ice-cold PBS-EDTA as described by Scriba et al.[43] The resulting perfusate was 
collected and centrifuged. The mononuclear cells were isolated from the resulting cell pellet by Ficoll 
density gradient centrifugation. In some experiments the peritoneal and pleural cavities were 
sequentially lavaged using 100 ml and 50 ml PBS, respectively. Bronchoalveolar lavage was performed 
by inserting a plastic cannula into the trachea and inflating the lungs three times with 10 ml of 
Ca2+/Mg+ free PBS using a syringe. Following lavage procedures tissues of interest were removed and 
dissected for disaggregation and imaging. To remove the blood for some imaging experiments, 
euthanized animals were flushed with approximately 50 ml PBS via a syringe inserted into the left 
ventricle. Tissues for imaging were stored in PBS on ice and imaged within 2 h. Tissues for 
disaggregation, including liver, spleen and lung, were finely chopped in digestion solution containing 1 
mg/ml Collagenase IV (Worthington) and 20 ug/ml DNAse1 (Roche) and placed on ice until further 
processing (~1 g tissue/10 ml). Tissues in digestion solution were placed on a rocking platform at 37°C 
for 45 minutes prior to mashing through a 70 µm filter (Falcon). For all tissues other than the liver the 
cell pellet was collected by centrifugation at 400 g for 5 min and resuspended in FC buffer. Percoll 
density gradient centrifugation was used to isolate the liver mononuclear cell fraction, which was 
then subjected to red blood cell lysis, washed and resuspended in FC buffer, as previously 
described[44]. For each tissue the cell count was estimated using a hematology analyzer (estimated as 
white blood cell count) and 1 X 106 cells were stained for flow cytometry analysis.  
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Flow cytometry 
Cell preparations were stained for 45 min on ice in FC buffer containing unlabeled CD32 (BD 
Bioscience), to block Fc receptor binding, with antibody cocktails comprising combinations of CD3-
FitC, CD161-AF647, HIS48-FitC, CD11b/c-BV570, CD45R-BV785 (BD Biosciences), CD172-AF405 
(Novus), CD4-APC-Cy7, CD43 AF647 (Biolegend). For intracellular staining (CD68-AF647, BD 
Biosciences), following surface staining cells were fixed in 4 % paraformaldehyde for 10 min at room 
temperature, washed and stained with antibody in FC buffer containing 0.1 % saponin. Cells were 
washed twice following staining and resuspended in FC buffer containing 7AAD (Life Technologies) for 
acquisition using a Cytoflex flow cytometer (Becton Dickinson). Relevant single-color controls were 
used for compensation and unstained and fluorescence-minus-one controls were used to confirm 
gating strategies. Flow cytometry data were analysed using FlowJo 10 (Tree Star). Live single cells 
were identified for phenotypic analysis by excluding doublets (FSC-A > FSC-H), 7AAD+ dead cells and 
debris. Absolute cell counts were calculated by multiplying the frequency of the cell type of interest 
by the total mononuclear cell yield per gram of disaggregated tissue. 
 
Confocal microscopy and immunohistochemistry. 
Direct imaging of tissues was performed using a Nikon/Spectral Spinning Disc Confocal microscope (X-
1 Yokogawa spinning disc with Borealis modification). Ki67 staining was performed on 
paraformaldehyde-fixed paraffin-embedded liver tissue with heat-induced epitope retrieval in 10 mM 
sodium citrate buffer pH 6.0, rabbit anti-Ki67 (Abcam ab16667) and DAKO Envision anti-rabbit HRP 
detection reagents. 
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Statistics 
Statistical tests were performed using GraphPad Prism 7. Comparisons between control and treated 
groups were performed using the unpaired student’s t-test with Welch’s correction for unequal 
variance where population variance significantly differed (F test). 
 
Results 
Transgenic Csf1r-mApple rats on the outbred Sprague-Dawley (SD) background were generated by 
pronuclear injection using the same Csf1r-mApple cassette used previously to generate Csf1r-mApple 
mice[28]. The mouse Csf1r regulatory elements in this construct, which include the highly conserved FIRE 
sequence[45] are the same as used in the original mouse Csf1r-EGFP transgene[29]. One founder line that 
showed germ line transmission and expression of the reporter in blood cells was chosen for further detailed 
characterization.  
 
Expression of Csf1r-mApple in peripheral blood leukocytes 
Rat monocytes were reported to be uniformly positive for the myeloid markers CD172A (SIRPα), but varied in 
expression of CD43, HIS48, CD11c, CD4 and MHCII.[12] The Csf1r-mApple transgene provides an additional 
myeloid marker. CD172A+ myeloid cells in peripheral blood from Csf1r-mApple rats exhibited a spectrum of 
mApple expression (Figure 1A). Consistent with expression in mice with the same transgene[28], 
CD172A+/mApple+ myeloid cells included mAppleIntSSCHi granulocytes and SSCLow monocytes (Figure 1B). The 
monocyte population could be further segregated based on CD43 and HIS48 expression (Figure 1C). As 
previously reported, CD43Low monocytes expressed high levels of the granulocyte marker HIS48 whereas 
CD43Hi cells were HIS48Low (Figure 1C). There was also a small population of CD43Low/HIS48- cells (<5% of 
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monocytes) (Figure 1C), that may represent immature myeloid cells. As previously reported CD43Hi/HIS48Low 
‘non-classical’ monocytes selectively expressed CD4,[11] whereas median CD11b/c expression was higher in 
CD43Low/HIS48Hi ‘classical’ monocytes (Figure 1D). The rat monocyte subpopulations were not clearly 
delineated consistent with evidence, as in humans and mice, that they represent a differentiation series.[11] 
There was a spectrum of mApple expression in both the HIS48Low/CD43Hi and HIS48Hi/CD43Low monocyte 
populations (Figure 1E). Amongst the non-myeloid (CD172A-) population approximately 90% of CD45R+ 
(B220+) peripheral blood B cells expressed detectable mApple (Figure 1A,F), similar to the profile observed in 
Csf1r-mApple mice.[28] 
 
CD43Hi/HIS48Low non-classical monocytes were present in approximately 4-fold excess compared to 
CD43Low/HIS48Hi classical monocytes (Figure 1C). Previous studies have reported an excess of CD43Hi:CD43low 
monocytes in peripheral blood ranging from approximately 2-fold to 8-fold [11] [12]. Different gating 
strategies or rat genetic backgrounds may have contributed to this discrepancy. The latter study also 
employed whole body perfusion with PBS-EDTA in an attempt to include the marginal pool of monocytes but 
did not compare the perfusate to more conventional sampling of the bulk flow.[11] Given the nature of 
surface markers including selectin ligands, and the proposed function of non-classical monocytes in 
monitoring the vessel wall, one possibility was that the CD43hi cells are selectively marginated. We compared 
the profiles of cells obtained from bulk flow with those obtained by flushing the circulation with PBS-EDTA. 
The PBS-EDTA eluate contained abundant leukocytes, but there was no selective enrichment in monocyte 
subsets or other mononuclear cells (data not shown).  
 
Expression of Csf1r-mApple in the bone marrow.  
Approximately 50% of bone marrow (BM) cells expressed mApple, of which ~50% co-expressed CD172A 
(Figure 2A). The large majority of mAppleHi/CD172A- non-myeloid cells expressed the B cell marker CD45R 
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(B220) as in peripheral blood (Figure 2B). There was no detectable expression of mApple in CD3+ T cells or 
CD161+ NK cells (data not shown). Bone marrow (BM) myeloid CD172A+/mApple+ cells comprised a minor 
(10%) population of SSCHi cells (putative granulocytes) and 2 SSCLow/Int populations (Figure 2C). 
CD172A+/mApple+/SSCLow/Int monocytes/macrophages fell into 2 sub-populations distinguished by reciprocal 
high expression of CD43 and HIS48 (~70:30 ratio) (Figure 2D). CD43Hi cells expressed CD11b/c and CD4, 
whereas HIS48Hi BM cells were largely negative for both markers (Figure 2E). On cytospin analysis of sorted 
cells, the SSCInt/CD43Hi BM cells had irregular nuclei and abundant cytoplasm consistent with identity as 
resident marrow macrophages, whereas the SSCLow/HIS48Hi BM cells resembled monocytes, with round 
nuclei and relatively scant cytoplasm (not shown). CD68, an endosomal protein commonly-employed as a 
macrophage marker in rats, was most highly expressed in SSCHi granulocytes, followed by SSCInt/HIS48Low 
myeloid cells, again consistent with identity as resident macrophages, but was poorly expressed in SSCLow 
monocyte-like cells (Figure 2F). CD68 was not routinely included in phenotyping panels because fixation and 
permeabilization for intracellular staining compromised staining of several antibodies of interest. Overall, our 
data show that Csf1r-mApple transgene expression in the bone marrow is restricted to cells that express 
myeloid (CD172A, CD11b/c, HIS48, CD68) or B cell (CD45R) markers. Accordingly, we infer that the transgene 
is not expressed in lineage-negative cells, consistent with previous studies of the regulation of mouse Csfr1r 
transcription during lineage commitment.[46] 
 
Csf1r-mApple transgene expression in rat serous cavities and tissues. 
Mouse serous cavities contain two populations of macrophage lineage cells distinguished by surface 
markers. A population of small F4/80low short-lived cells turns over continuously from monocytes but can 
also contribute to replacement of the long-lived resident population.[47] Equivalent populations have been 
suggested in humans[48], but have not been identified in rats. We isolated cells from the peritoneal and 
pleural cavities to investigate the expression of myeloid markers on Csf1r-mApple+ cells and to seek 
equivalent heterogeneity. Approximately 70% of peritoneal and pleural exudate cells expressed mApple, 95% 
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of which co-expressed CD172A (Figure 3A,D). In contrast to the uniform high reporter expression in mouse 
peritoneal macrophages[28], there was a large spectrum of Csf1r-mApple expression in rat peritoneal and 
pleural cells. 10-15% of CD172A+/mApple+ cells were also SSCHi (Figure 3B,E) and resembled granulocytes on 
cytospins (not shown). The majority (>90%) of SSCLow resident macrophages homogeneously expressed CD4 
and CD11b/c (Figure 3C,F), but very low or no HIS48 and CD43 (not shown). Minor populations of 
CD11b/cLow/Neg. (5-10%) and CD11b/c+/CD4- were also identified (Figure 3C,F). In both the peritoneal and 
pleural cavities, mApple+/CD172A+/SSCHi granulocytes, but not SSCLow monocyte-macrophages, expressed 
CD68 (Figure 3G,H and data not shown). Consistent with published data[49], CD163, another commonly used 
rat tissue macrophage marker, which is not expressed on the surface of blood monocytes[49], labelled 
approximately 50% of peritoneal mApple+/CD172A+/SSCLow cells but did not define an obvious subpopulation 
(Figure 3G,H). Overall, the marker profile suggests that the peritoneal macrophages represent a spectrum of 
maturation. Consistent with that view, cytospins of flow cytometry-sorted peritoneal populations revealed a 
broad spectrum of morphologies from monocyte-like to mature macrophage (Figure 3I). We also assessed 
expression of the transgene in bronchoalveolar lavage cells. Like macrophages of serous cavities, lavage cells 
expressed very high levels of mApple, were highly autofluorescent and expressed CD172A, CD4 and CD43, 
but not HIS48 and CD11b/c (Figure 3J and data not shown). 
 
Csf1r-mApple expression in rat tissues.  
To assess the expression of Csf1r-mApple in tissue macrophage populations in situ, we imaged a variety of 
fresh unfixed tissues from adult male and female reporter rats using a spinning disc confocal microscope. 
Representative images are shown in Figure 4. The abundance, distribution and stellate morphology of cells 
expressing detectable Csf1r-mApple in a diverse array of tissues mirrors previous analysis of mouse Csf1r 
transgenes[28, 29] and, in most cases, the location of mouse macrophages defined by the F4/80 antigen.[50] 
Consistent with the expression of the transgene in blood and bone marrow B cells Csf1r-mApple was 
apparently abundant in structures that resemble lymphoid follicles in the spleen, lymph nodes and Peyer’s 
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patches (Figure 4). One striking finding made possible with the transgene is the imaging of macrophages in 
skeletal, cardiac and smooth muscle of the diaphragm and muscularis externa of the gut (Figure 4). 
Macrophages of the diaphragm are implicated in control of lymphangiogenesis[51, 52] and those of 
muscularis externa in the regulation of gut motility in the mouse[53]. In each location, macrophages are 
abundant and spread in the plane of the muscle fibres. There have been few published studies of skeletal 
muscle macrophages in the mouse[54], but the expression of the transgene is consistent with much older 
studies of the localization of ED2 (CD163) and ED3 (CD169) in rat skeletal muscle[55].   
 
In mice, the Csf1r-EGFP transgene provides a sensitive marker for imaging microglia[56]. For reasons that are 
not clear, mApple was readily detected by flow cytometry in CD45LowCD11b+ microglia in Csf1r-mApple 
mice[28] but the reporter gene was difficult to detect in whole mount brain preparations. This was also the 
case in Csf1r-mApple rats. Microglia were readily detectable in the brain meninges (Figure 4) but only faintly 
labelled in whole mounts of brain regions, although Csf1r-mApple+ myeloid cells (CD11b/c+, ~20 % of brain 
cells) were readily detected in disaggregated brain of Csf1r-mApple rats (data not shown). We conclude that 
there is some form of quenching of the mApple signal in nervous tissue. 
 
The effect of CSF1-Fc administration on circulating monocytes and tissue macrophage populations.  
The main purpose of the generation and characterization of the Csf1r-mApple transgene was to provide a 
marker for studies of macrophage biology in the rat. In particular, our focus is on potential therapeutic 
applications of CSF1 and the role of CSF1R signalling in development.[8] In neonatal rats, the administration 
of a CSF1-Fc fusion protein expanded the macrophage populations of the liver and other tissues but did not 
increase the blood monocyte count.[9] However, much earlier studies demonstrated increased peripheral 
blood monocytes in CSF1-treated adult rats.[57] We therefore decided to investigate the effect of CSF1-Fc in 
adult rats using the Csf1r-mApple transgene as a marker. This study also serves to validate the CSF1-
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dependence of mApple+ tissue macrophage populations identified with the transgene by direct imaging and 
by flow cytometry analysis of disaggregated tissues. Using the same protocol as employed previously in 
mice,[23] in separate experiments we injected cohorts of adult male and female Csf1r-mApple rats with pig 
CSF1-Fc (1 mg/kg) on each of 4 days, sacrificed them on the 5th day and harvested cell populations and 
tissues for analysis.  
 
Consistent with the findings in mice and pigs, CSF1-Fc treatment produced a marked increase in the size of 
the liver and spleen in both male and female rats (Figure 5A,B). Liver growth was associated with an increase 
in the number of Ki67+ hepatocytes as well as non-parenchymal cells (Figure 5C). In the blood we confirmed 
an ~4-fold increase in total leukocytes, and a 4-fold increase in monocytes (Figure 5D-E), but no change in 
granulocytes or other hematological parameters (not shown). Consistent with these findings, flow cytometry 
analysis revealed an ~3-fold increase in the Csf1r-mApple+ mononuclear cell population in peripheral blood 
(Figure 5F). There was no apparent change in the relative proportions of HIS48Hi and CD43Hi monocytes, but 
the minor population of HIS48-/CD43Low monocytes almost completely disappeared upon CSF1-Fc treatment 
(p=0.04, data not shown). The monocytosis initiated in response to CSF1-Fc treatment was associated with 
an increased prevalence of CD172A+/Csf1r-mApple+ cells in the BM, which was attributable to an increase in 
the SSCLow/HIS48Hi cells shown previously to resemble monocytes (Figure 2, Figure 6A-C). In the peritoneum 
CSF1-Fc treatment modestly increased the total yield of exudate cells (approximately 1.5-fold, p=0.06), 
without changing the proportions of cells positive for CD172A.   
 
The combination of the transgenic reporter and whole mount imaging enabled a global overview of the 
impact of CSF1-Fc treatment. An increase in both the size of the macrophages and their abundance was 
visibly obvious in images of fresh tissue examined using the spinning disc confocal. Figure 7 shows 
representative images of the lung, liver, diaphragm, mesentery, mesenteric lymph node, Peyer’s Patches, 
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colon and isolated lymphoid follicles with colonic patches from control and CSF1-Fc-treated Csf1r-mApple 
rats. In the liver, the obvious massive increase in Csf1r-mApple+ cells appeared to involve smaller, less 
stellate monocyte-like cells. Consistent with findings in the intestinal muscularis externa of CSF1-Fc treated 
mice,[28] individual Csf1r-mApple expressing macrophages in the diaphragm, where they can be readily 
imaged, were spread in the plane of the muscle and appeared larger and less ramified (Figure 7). The 
mesentery similarly provides a location where adipose tissue macrophages can be readily imaged. Csf1r-
mApple+ cells were distributed between adipocytes in control rats, but in CSF1-Fc treated mice they 
appeared larger and surrounded each adipocyte (Figure 7).  
 
To confirm the substantial expansion of the tissue macrophage populations observed with direct imaging we 
disaggregated selected tissues and analyzed cell surface marker expression. In saline treated control rats 
approximately 45% of spleen cells expressed Csf1r-mApple, 80-90% of which co-expressed CD45R and lacked 
expression of CD172A, CD11b/c, CD43 and HIS48, consistent with expression by B cells (Figure 8A and data 
not shown). In contrast to other tissues in which  
CD172A-/CD45R+ cells exhibited intermediate mApple expression, the spleen contained an mAppleHi 
population (Figure 8A). CSF1-Fc treatment increased splenic white blood cells (WBC) approximately 2-fold, 
including an increase in the proportion and number of mApple+/CD172A+ myeloid cells (p=0.005 and 
p=0.028, respectively), but no significant change in the mApple+/CD172A- compartment (Figure 8B). The 
increase in the myeloid compartment was driven by an increase in SSCLow monocyte-macrophages, including 
CD43Low cells with variable CD4 expression and a CD43Hi/CD4Hi sub-population (Figure 8C). Both CD172A+ 
monocyte-macrophage populations were CD11b/c+ and the majority were HIS48- (data not shown). Spleen 
mApple+/CD172A+ myeloid cells also included a population of relatively granular cells (Figure 8A), which were 
uniformly HIS48+/CD43+ and not affected by CSF1-Fc administration.   
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In the liver of saline-treated control rats, approximately 40% of non-parenchymal cells expressed mApple, of 
which 60% expressed CD172A (Figure 8D). CSF1-Fc treatment increased the yield of mononuclear cells after 
liver disaggregation >5-fold (p=0.007) and dramatically increased the proportion and number of 
CD172A+/mApple+ cells (Figure 8E), in particular CD172A+/SSCLow monocyte-macrophages with intermediate 
mApple expression. In control animals, 3 populations of liver monocyte-macrophages with distinct 
phenotypes were identified: CD43-/CD4-/mAppleInt, CD4+/CD43-/mAppleInt and CD4+/CD43+/mAppleHi (Figure 
8D). CSF1-Fc treatment led to increases in all 3 sub-populations, especially CD4+CD43- cells (Figure 8F).  
 
Whole mount imaging of the lung suggested that there was a substantial increase in the number of Csf1r-
mApple+ cells in this organ in response to CSF1-Fc treatment (Figure 7). The lung has not previously been 
examined in detail, but in mouse we showed that injection of labelled CSF1-Fc accesses interstitial but not 
bronchoalveolar macrophages.[28] Consistent with the imaging data, CSF1-Fc treatment induced a 
significant increase in mApple+/CD172A+ cells that were released by enzymic disaggregation of the lung 
(Figure 8G,H). As in other tissues, in both control and CSF1-Fc treated lungs, these cells varied in granularity. 
The SSClow monocyte-macrophage population could be subdivided based upon CD43 and CD4 expression, 
with CD43Hi/CD4+ cells comprising 70% of the total (Figure 8G). CSF1-Fc increased the SSClow population 
without changing the relative proportion of CD43Hi cells (Figure 8I). The SSCHi and SSCInt granulocytic cells had 
a similar surface marker profiles; CD43+/HIS48+/CD4-/CD11b/c+ (data not shown). Neither 
CD172A+/SSCHi/SSCInt nor Csf1r-mApple+/CD172-/CD45R+ B cells were affected by CSF1-Fc administration 
(Figure 8H,I).   
 
Discussion 
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The 7.2kb mouse Csf1r promoter cassette used to generate the Csf1r-mApple transgenic rat line produced 
consistent position and copy number-independent expression of reporter genes in multiple independent 
mouse lines[28, 29, 58] and was also used to generate Csf1r-cre recombinase transgenes for lineage trace 
studies[30]. The expression of the reporter gene in this construct depends upon an enhancer, the Fms 
Intronic Regulatory Element (FIRE)[29] that is highly-conserved in vertebrates[45]. A FIRE-like sequence, in 
the same relative location in the chicken CSF1R locus, is also required for expression of reporter genes in 
macrophages in chicken transgenic lines[31] and a lentivirus containing mouse FIRE was shown previously to 
able to direct myeloid-specific expression in rat, human, pig, cow, sheep and even chicken[59]. FIRE is 96 % 
identical between mouse and rat and there only 5 transversions none of which affects the documented 
binding sites for transcription factors[60]. The 7.2kb mouse Csf1r promoter used to generate the reporter rat 
line can be aligned across its whole length with the rat Csf1r locus with approximately 85 % 
conservation. Most differences are due to repeat insertions and expansion. All the regulatory elements in the 
proximal promoter (reviewed in[60]) are also conserved between mouse and rat. The widespread expression 
of Csf1r-mApple in macrophage lineage cells in the reporter rat supports the view that the regulation is 
conserved. Notwithstanding that view, we recently demonstrated that germ-line deletion of FIRE in mice 
leads to selective loss of CSF1R expression in monocytes and only a subset of tissue macrophages[61].  There 
are likely to be regulatory elements immediately upstream of the proximal promoter region[58] and within 
the upstream Pdgfrb gene[60] that contribute to Csf1r regulation. In a detailed study of the role of CSF1R in 
brain development, Erblich et al[62] found that Csf1r-EGFP expression accurately reflected the presence of 
Csf1r mRNA exclusively in microglia. Several studies have suggested that CSF1R can be expressed in neurons 
and in some epithelia. One such study claimed that CSF1R was expressed in Paneth cells in the intestinal 
crypt, but this was recently demonstrated not to be the case and Csf1r-EGFP expression in the lamina propria 
accurately reflected the expression of Csf1r mRNA exclusively in macrophages including those closely-
associated with the crypts[63]. In rat intestine there was a similar close apposition of Csf1r-mApple+ cells 
with the crypts, and the transgene was not expressed by epithelial cells. We have similarly seen no evidence 
for transgene expression in neurons or in any other location in tissues inconsistent with restriction to 
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hematopoietic cells. The analysis of disaggregated tissues by flow cytometry strongly supports the restriction 
of transgene expression in tissues to monocyte/macrophage lineage cells, and generally low expression in 
granulocytes and B cells.  
 
The Csf1r-mApple reporter provides an additional marker for blood monocytes. As previously reported in 
studies in inbred PVG[11] and outbred SD rats[12], the CD43Hi “non-classical monocyte population was 
dominant in our SD Csf1r-mApple rats (4-fold compared to CD43Low “classical” monocytes). As in a previous 
study, rat monocytes were also distinguished by expression of CD4 and the granulocyte marker HIS48[12]. 
CSF1-Fc treatment significantly increased peripheral blood monocyte count, as has been shown in other 
species. In mice, the relative abundance of the monocyte populations varies in different reports and may be 
strain and method dependent. On an outbred genetic background, the CD43+/Ly6CLow non-classical 
monocytes comprised around 60% of total monocytes[14]. However, in C57BL/6 mice Ly6CHi monocytes are 
clearly in the substantial majority[28, 64]. In humans the non-classical CD16+ monocytes constitute a minor 
population (~10%), but this depends upon the gating strategy and changes with disease status[65-67]. The 
delineation of a definitive “non-classical” monocyte is also difficult in other species[32, 68]. The original 
identification of CD43Hi monocytes in rats reported a similar relative abundance to mice[69], but subsequent 
studies indicated an apparent excess of CD43Hi non-classical cells[11, 12, 70]. The identification of an excess 
of CD43Hi non-classical monocytes in the rat depends obviously upon the definition of monocytes. The Csf1r-
mApple transgene provides an additional informative marker.  
 
The abundance and regular distribution of macrophages within rat tissues is remarkably consistent. 
Monocyte-macrophage homeostasis has been attributed to a combination of regulated growth factor 
availability and either mutual repulsion or competition for spatially-defined niches within tissues[17, 21, 71]. 
In previous studies, we showed that labelled CSF1-Fc injected into the circulation can access all tissue 
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macrophage populations other than brain microglia and bronchoalveolar macrophages in mice[28] and that 
short-term CSF1-Fc administration increases the abundance of multiple tissue macrophage populations, in 
part due to resident macrophage proliferation[9, 23, 72, 73]. CSF1-Fc treatment also increased liver and 
splenic macrophage content in neonatal rats[9]. At this age, resident macrophage proliferation appeared to 
be the dominant mechanism since there was no impact on monocyte production. By contrast, in adult rats, 
CSF1-Fc treatment promoted a significant increase in circulating blood monocytes, and a massive expansion 
of tissue macrophages in every organ investigated. Changes in size and morphology were also evident. The 
lack of CSF1-Fc-induced monocytosis thus appears specific to neonates and adult rats respond to CSF1-Fc in 
a similar manner to mice and pigs[23, 24, 73]. Although CSF1 has been shown to promote monocyte 
maturation in mice and humans[74], we did not observe any difference in the relative proportions of 
monocyte subsets upon CSF1-Fc treatment. CSF1-Fc treatment of adult rats also promoted hepatomegaly 
(associated with hepatocyte and non-parenchymal cell proliferation) and splenomegaly, as observed in 
neonatal rats as well as mice and pigs[9, 23, 73]. The impacts of CSF1-Fc treatment in mice are age- and 
gender-dependent (unpublished data). In this study, we observed a greater impact of CSF1-Fc treatment on 
liver size in 8-week old female compared to 11-week old male rats. The underlying mechanism is not known, 
however CSF1-dependent liver macrophages may interact with other pathways controlling sex-specific liver 
gene expression, organism growth and other functions. 
 
Tissue macrophage heterogeneity has been extensively studied in mice (e.g. www.Immgen.org), and some 
phenotypic and/or functional characteristics have been translated to human macrophages and informed our 
understanding of macrophage heterogeneity and plasticity in health and disease. Although rats are 
considered to be superior to mice for modelling many aspects of human physiology, including cardiovascular 
disease and cognition[1], there is a paucity of studies on rat tissue macrophages, in part due to the limited 
range of antibodies available. Here we use Csf1r-mApple to highlight and begin to dissect the remarkable 
macrophage heterogeneity in a diverse range of rat tissues. In addition to their differential expression on 
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circulating monocytes, CD43 and HIS48 have been reported as markers of monocyte-macrophage subsets in 
rat bone marrow, liver, lung and spleen[12]. We used Csf1r-mApple and CD172A to identify myeloid lineage 
cells in multiple tissues and investigated co-expression of CD11b/c and the monocyte-subset-specific 
markers CD43 and HIS48. We identified CD43Hi and HIS48Hi bone marrow populations that resembled 
macrophages and monocytes, respectively, and demonstrated a >3-fold increase in the HIS48Hi monocyte 
population in response to CSF1-Fc treatment. CSF1-Fc treatment also produced a dramatic increase in 
splenic monocyte-macrophages, including both CD43Hi and CD43Low sub-populations, the majority of which 
lacked HIS48 expression. The largest impact of CSF1-Fc treatment was seen in the liver, with significant 
increases in 3 monocyte-macrophage populations distinguished by differential CD43 and CD4 expression. 
CSF1-Fc treatment also increased monocyte-macrophage content in the lung, with parallel increases in 
CD43Hi and CD43Low sub-populations. Although the available markers do not definitively distinguish 
monocytes, monocyte-derived macrophages and embryonic-derived macrophages, these data suggest CSF1-
Fc acts on multiple resident macrophage subsets and potentially promotes monocyte infiltration, consistent 
with data in mice, in which CSF1-Fc treatment promoted both monocyte infiltration and resident 
macrophage proliferation in the liver[73]. [75] Taken together, we show that CSF1-Fc treatment specifically 
expanded Csf1r-mApple/CD17A+ populations in every tissue examined, without impacting Csf1r-mApple+ 
granulocytes and B cells, consistent with their identification as monocyte-macrophage lineage cells and 
highlighting the systemic impact of CSF1-Fc. Although HIS48 robustly labelled granulocytes and has 
previously been reported as a marker of tissue macrophage subsets[12], we did not find this marker to be a 
universally applicable monocyte-macrophage marker. On the other hand, CD43 and CD4 reliably 
distinguished macrophage sub-populations in multiple tissues. Further detailed investigations will be 
required to understand the ontogeny and function of the rat tissue macrophage sub-populations identified. 
 
The propensity of immune cell reporter genes to be downregulated by inflammatory stimuli is a potential 
limitation to their use. For example, a human CD68 promoter-driven GFP transgenic macrophage reporter 
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mouse was shown to be superior to Cxcr3-GFP for studies of inflammation[75]. Csf1r-mApple expression in 
response to inflammatory stimuli has not yet been tested, however reporter downregulation has not 
previously been observed in Csf1r reporter mice in inflammatory settings, and there were no identifiable 
effects of CSF1-Fc treatment upon mApple expression in Csf1r-mApple rats. 
 
Circulating CSF1 is heavily buffered by macrophage-mediated clearance in the liver and spleen[21]. 
Nevertheless, increased circulating CSF1 has been measured in many different inflammatory and malignant 
disease states[76]. In obese patients, the level varied by an order of magnitude and was weakly correlated 
with insulin resistance[77]. Another study noted elevated circulating CSF1 in response to exercise and 
training[78]. Our key conclusion is that CSF1 is not saturating for any tissue macrophage populations. The 
results indicate that any increase in circulating CSF1 would drive increased macrophage numbers in every 
organ system. In effect, the mononuclear phagocyte system functions as a single regulated unit. The 
pleiotropic impacts need to be considered in any therapeutic application of either CSF1 or CSF1 antagonists.  
 
The major limitation of the Csf1r-mApple rat is that there are two populations of cells that express mApple 
that are clearly not macrophages. In mice, both Csf1r transgenes and Csf1r mRNA are expressed by 
granulocytes[33] but they do not express Csf1r protein unless starved of growth factors in vitro. They also do 
not bind labelled CSF1-Fc in vivo[28]. In several tissues, notably bone marrow, peritoneum and liver, we also 
identified Csf1r-mApple-/CD172A+ myeloid populations that exhibited high granularity and expressed the 
granulocyte marker HIS48. Circulating B lymphocytes expressed Csf1r-mApple in rats, as they do in mice[28]. 
We have extended that observation to demonstrate the expression in B cells in multiple organs, including 
spleen and lymph node. As noted above, the Csf1r promoter is active in B cells[34], but there is little to no 
detectable Csf1r mRNA in purified mouse B cells in any state of activation (www.biogps.org; 
  
 
This article is protected by copyright. All rights reserved. 
 
www.immgen.org). It may be that elements outside the promoter construct used, as well as chromatin 
architecture, serve to restrict B cell Csf1r expression.  
 
In summary, we report the generation of the first macrophage reporter transgene in rats. A separate rat 
macrophage reporter line utilising the human CD68 promoter[75] driving EGFP has also recently been 
generated (Kevin J Wollard, personal communication), which will be valuable for comparative studies. Csf1r-
mApple is robustly expressed in monocyte-macrophage lineage cells. We have demonstrated the utility of 
Csf1r-mApple for direct imaging and flow-cytometric identification of rat tissue macrophage populations and 
for monitoring impacts of modifiers of the mononuclear phagocyte system, exemplified by CSF1-Fc. The 
mApple reporter will enable two-colour imaging of cell-cell interactions with more commonly-applied EGFP 
reporters and facilitate more detailed investigations into rat monocyte and tissue macrophage subsets, 
which are currently limited by the available markers.   
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Figure 1. Csf1r-mApple expression in rat peripheral blood leukocytes. Peripheral blood (PB) was 
collected from Csf1r-mApple rats and analyzed by flow cytometry. (A) Csf1r-mApple expression in 
CD172A+ and CD172A- PB leukoyctes. Csf1r-mApple+/CD172A+ cells comprised SSCHi granulocytes and 
SSCLow monocytes (B), which could be further divided into HIS48Hi/CD43Low (red), HIS48Low/CD43Hi 
(green) and HIS48-/CD43Low (blue) subpopulations (C) exhibiting differential CD4 and CD11b/c 
expression (D) and a spectrum of mApple expression (E). (F) CD45R expression on CD172A- PB 
leukocytes. 
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Figure 2. Csf1r-mApple expression in rat bone marrow. Bone marrow (BM) was collected from Csf1r-
mApple rats and analyszed by flow cytometry. (A) Csf1r-mApple expression in CD172A+ and CD172A- 
BM cells. (B) CD45R expression on CD172A- BM cells. 
Csf1r-mApple+/CD172A+ cells comprised SSCHi granulocytes, SSCInt and SSCLow monocyte/macrophages 
(C). CD43 and HIS48 (D) and CD11b/c and CD4 (E) expression on Csf1r-mApple+/CD172A+/SSCInt and 
mApple+/CD172A+/SSCLow BM cells. CD68 expression on Csf1r-mApple+/CD172A+ BM cells (E, 
population cell counts normalized to mode).  
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Figure 3. Csf1r-mApple expression in rat peritoneal and pleural cavity and alveolar cells. Peritoneal, 
pleural and bronchoalveolar cells were collected from Csf1r-mApple rats by lavage and analyzed by 
flow cytometry. Csf1r-mApple expression in CD172A+ and CD172A- peritoneal (PT, A) and pleural (PL, 
D) cells. PT and PL Csf1r-mApple+/CD172A+ cells comprised SSCHi granulocytes and SSCLow 
monocyte/macrophages (arrow) (B,E). SSCLow monocyte/macrophages exhibited differential CD11b/c 
expression (C,F). CD163 and CD68 expression on peritoneal monocyte-macrophages (G) and 
granulocytes (H). Cytospin analysis of Csf1r-mApple+/CD172A+/SSCLow peritoneal monocyte-
macrophages (I, arrow and arrow head indicate macrophage and monocyte morphology, respectively. 
20X magnification). Csf1r-mApple expression in CD172A+ bronchoalveolar lavage (BAL) cells (J).    
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Figure 4. Localization of the Csf1r-mApple+ cells in rat tissues. Whole-mount imaging of freshly isolated 
meninges, optic nerve, liver, kidney, lung, cardiac muscle, diaphragm, muscularis externa of the gut, 
skeletal muscle, skin epidermis, brown adipose tissue (BAT), white adipose tissue (WAT), pancreas 
(including islet), spleen, mesenteric lymph node (MLN), inguinal lymph node (ILN), Peyer’s patch, and 
colon from Csf1r-mApple transgenic rats. Scale bars represent 50µM not including Peyer’s patch and 
colon, which is 100µM. 
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Figure 5. CSF1-Fc administration increases blood monocyte count and promotes hepatomegaly and 
splenomegaly. Csf1r-mApple rats were administered 1 mg/kg CSF1-Fc daily for 4 days prior to sacrifice 
on day 5. Liver (A) and spleen (B) weight/body weight ratio, liver Ki67 expression (C, D, 20X 
magnification), and peripheral white blood cell (WBC) count (E) and monocyte proportion (F) in PBS 
compared to CSF1-Fc-treated rats. 
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Figure 6. Impact of CSF1-Fc administration on bone marrow leukocytes. Bone marrow (BM) cells were 
harvested from Csf1r-mApple rats administered 1 mg/kg CSF1-Fc daily for 4 days prior to sacrifice on 
day 5. The impact of CSF1-Fc treatment on Csf1r-mApple CD172A+ and CD172A- BM myeloid cells (A) 
and CD172A+/SSCInt (solid arrow) and CD172A+/SSCLow (dashed arrow) BM cells in control and CSF1-Fc-
treated rats (B-C). 
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Figure 7: Localization of Csf1r-mApple+ cells in tissues of CSF1-Fc-treated rats. Whole mount images of 
freshly isolated lung, liver, diaphragm, mesentery, mesenteric lymph node (MLN), Peyer's patches 
(PP) and their surrounding villi (V), colon (including isolated lymphoid follicles (ILF)) and colonic 
patches (CP) from saline- and CSF1-Fc-treated (below) Csf1r-mApple rats. Scale bars represent 50 µM 
in lung, liver, diaphragm, mesentery and MLN. Scale bars represent 100 µM in Peyer’s patches, colon 
and colonic patches. 
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Figure 8. Csf1r-mApple expression in rat spleen, liver and lung leukocyte populations and the impact of 
CSF1-Fc administration. Spleens, livers and lungs were harvested from Csf1r-mApple rats administered 
1 mg/kg CSF1-Fc daily for 4 days prior to sacrifice on day 5. Csf1r-mApple expression in CD172A+ and 
CD172A- splenocytes (A) and their abundance (B) in control and CSF1-Fc-treated rats. Csf1r-
mApple+/CD172A+/SSCLow spleen cells comprised CD43Low and CD43Hi sub-populations (A,C). Csf1r-
mApple expression in CD172A+ and CD172A- liver leukocytes (D) and their abundance (E) in control 
and CSF1-Fc-treated rats. 
Csf1r-mApple+/CD172A+/SSCLow liver cells comprised CD43-/CD4-, CD43-/CD4+ and CD43+/CD4+ sub-
populations (D,F). Csf1r-mApple expression in CD172A+ and CD172A- lung leukocytes (G) and their 
abundance (H) in control and CSF1-Fc-treated rats. The impact of CSF1-Fc treatment on 
CD172A+/SSCHi and CD172A+/SSCLow subpopulations (C).    
